The latest guidance on the simultaneous design of virtually active and non-hemolytic peptides.

Expert Opin Drug Discov

Laboratory of Fundamental and Applied Research of Quality and Technology of Food Production, Moscow State University of Food Production, Moscow, Russian Federation.

Published: October 2022

Download full-text PDF

Source
http://dx.doi.org/10.1080/17460441.2022.2128756DOI Listing

Publication Analysis

Top Keywords

latest guidance
4
guidance simultaneous
4
simultaneous design
4
design virtually
4
virtually active
4
active non-hemolytic
4
non-hemolytic peptides
4
latest
1
simultaneous
1
design
1

Similar Publications

Background: Kidney transplant recipients are uniquely exposed to the disordered bone metabolism associated with chronic kidney disease beginning before transplantation followed by chronic corticosteroid use after transplantation. Previous efforts to synthesize the rapidly accruing evidence regarding estimation and management of fracture risk in kidney transplant recipients are outdated and incomplete.

Objective: To synthesize the evidence informing the overall incidence, patient-specific risk prediction, and methods of prevention of fractures in patient living with a kidney transplant.

View Article and Find Full Text PDF

Objectives: To describe the workflow and value of three-dimensional rotational angiography (3DRA) in percutaneous pulmonary valve implantation (PPVI).

Background: 3DRA offers visualization of the entire topography in the chest and may enhance safety and reduce the risk for complications in PPVI through improved pre-procedural planning and per-procedural guidance.

Methods: All PPVI procedures with the use of 3DRA performed between August 2011 and December 2022 were reviewed.

View Article and Find Full Text PDF

Recent Advances in enhancer of zeste homolog 2 Inhibitors: Structural insights and therapeutic applications.

Bioorg Chem

December 2024

Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, PR China. Electronic address:

Enhancer of Zeste Homolog 2 (EZH2) is overexpressed in many malignancies and plays a critical role in cancer progression. Therefore, it is considered a promising target for therapeutic intervention. Although several EZH2 inhibitors have entered clinical trials, only one has received FDA approval.

View Article and Find Full Text PDF

Cell salvage for the management of postpartum haemorrhage.

Cochrane Database Syst Rev

December 2024

Liverpool Reviews and Implementation Group, Department of Health Data Science, University of Liverpool, Liverpool, UK.

Rationale: Postpartum haemorrhage (PPH), defined as a blood loss of 500 mL or more within 24 hours of birth, is the leading global cause of maternal morbidity and mortality. Allogenic blood transfusions are a critical component of PPH management, yet are often unfeasible, particularly in resource-poor settings where maternal morbidity is highest. Autologous cell salvage in the management of PPH has been proposed to combat limitations in access to allogenic blood and potential transfusion-related risks.

View Article and Find Full Text PDF

Current and future perspectives on pregnancy and lactation-associated osteoporosis.

Front Endocrinol (Lausanne)

December 2024

Section of Endocrinology & Investigative Medicine, Imperial College London, London, United Kingdom.

Normal pregnancy and lactation have a marked physiological impact on maternal bone metabolism. This impact is usually temporary and reversible, but some women sustain fragility fractures whilst pregnant or lactating, termed pregnancy and lactation-associated osteoporosis (PLO). These fractures have severe negative consequences on their quality of life, at what is a crucial stage in a mother's life.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!